---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-012804"
form_type: "8-K"
ticker: "IMMX"
cik: "0001873835"
company_name: "Immix Biopharma, Inc."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:42:02.543848+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Immix Biopharma raises $9.1M in PIPE; Nancy Chang appointed to board

## Summary
- Sold 3,831,216 shares at $2.37/share and warrants for 2,873,417 shares at $2.00/share.
- Gross proceeds ~$9.1M for working capital and general corporate purposes; closed on Sept 5, 2025.
- Warrants are non-transferable, exercisable for 10 years, and only for cash.
- Nancy Chang, Ph.D. appointed to board effective Sept 8, 2025; co-founded Tanox (XOLAIR developer).
- Resale registration statement to be filed with SEC within 30 days of closing.

## SEC filing metadata
- accession: 0001493152-25-012804
- form_type: 8-K
- ticker: IMMX
- cik: 0001873835
- company_name: Immix Biopharma, Inc.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873835/000149315225012804/0001493152-25-012804-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873835/000149315225012804/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-012804
- JSON: https://secwatch.observer/filing/0001493152-25-012804.json
- Plain text: https://secwatch.observer/filing/0001493152-25-012804.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.